BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Treatment
128 results:

  • 1. Dynamics of Soluble Forms of the Immune Checkpoint Components PD-1/PD-L1/B7-H3, CD314/ULBP1, and HLA-G in Peripheral Blood of Melanoma Patients Receiving Blockers of Programmed Cell Death Protein PD-1.
    Gershtein ES; Mochalova AS; Korotkova EA; Samoilova EV; Vashketova OI; Kuz'min YB; Sokolov NY; Kushlinskii NE
    Bull Exp Biol Med; 2023 Aug; 175(4):481-486. PubMed ID: 37773572
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. 3-deazaneplanocin A, a histone methyltransferase inhibitor, improved the chemoresistance induced under hypoxia in melanoma cells.
    Hosokawa M; Tetsumoto S; Yasui M; Kono Y; Ogawara KI
    Biochem Biophys Res Commun; 2023 Oct; 677():26-30. PubMed ID: 37542772
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. pH Switchable Nanozyme Platform for Healing skin Tumor Wound Infected with Drug-Resistant Bacteria.
    Yan Y; Wang M; Zhao M; Zhang J; Liu Y; Gao X
    Adv Healthc Mater; 2023 Nov; 12(28):e2301375. PubMed ID: 37399839
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Methyltransferase-independent function of enhancer of zeste homologue 2 maintains tumorigenicity induced by human oncogenic papillomavirus and polyomavirus.
    Khattri M; Amako Y; Gibbs JR; Collura JL; Arora R; Harold A; Li MY; Harms PW; Ezhkova E; Shuda M
    Tumour Virus Res; 2023 Dec; 16():200264. PubMed ID: 37244352
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. In Vivo Acute Toxicity Studies of Novel Anti-Melanoma Compounds Downregulators of hnRNPH1/H2.
    Velayutham S; Seal T; Danthurthy S; Zaias J; Smalley KSM; Minond D
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830718
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Screening costs associated with donor selection for fecal microbiota transplantation for treatment of PD-1 refractory melanoma patients.
    Fortman D; Avellan MGP; Hurd D; Schwartz M; Dubner H; Hewitt C; Berton S; Ernst S; Rose A; Zarour HWH; Davar D
    Melanoma Res; 2023 Apr; 33(2):136-148. PubMed ID: 36806616
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Adult orbital xanthogranuloma: long-term follow-up of treated cases.
    Detiger SE; Hötte GJ; Verdijk RM; de Keizer ROB; van Hagen PM; van Laar JAM; Paridaens D
    Eye (Lond); 2023 Aug; 37(12):2475-2481. PubMed ID: 36526862
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development of new bioactive molecules to treat breast and lung cancer with natural myricetin and its derivatives: A computational and SAR approach.
    Akash S; Kumer A; Rahman MM; Emran TB; Sharma R; Singla RK; Alhumaydhi FA; Khandaker MU; Park MN; Idris AM; Wilairatana P; Kim B
    Front Cell Infect Microbiol; 2022; 12():952297. PubMed ID: 36237438
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche.
    Seitz T; John N; Sommer J; Dietrich P; Thasler WE; Hartmann A; Evert K; Lang SA; Bosserhoff A; Hellerbrand C
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232829
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Characterizing DNA methylation signatures and their potential functional roles in Merkel cell carcinoma.
    Gujar H; Mehta A; Li HT; Tsai YC; Qiu X; Weisenberger DJ; Jasiulionis MG; In GK; Liang G
    Genome Med; 2021 Aug; 13(1):130. PubMed ID: 34399838
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma.
    Kilgour JM; Shah A; Urman NM; Eichstadt S; Do HN; Bailey I; Mirza A; Li S; Oro AE; Aasi SZ; Sarin KY
    Clin Cancer Res; 2021 Sep; 27(17):4717-4725. PubMed ID: 34362809
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Medicaments and oral healthcare. Medicaments potentially inducing angioedema and/or urticaria].
    de Baat C; Zweers PGMA; Rozema FR; Bolling MC; Vissink A
    Ned Tijdschr Tandheelkd; 2021 May; 128(5):269-276. PubMed ID: 34009210
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment.
    Grote S; Ureña-Bailén G; Chan KC; Baden C; Mezger M; Handgretinger R; Schleicher S
    Cells; 2021 Apr; 10(5):. PubMed ID: 33925968
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular Hydrogen as a Potential Clinically Applicable Radioprotective Agent.
    Hirano SI; Ichikawa Y; Sato B; Yamamoto H; Takefuji Y; Satoh F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925430
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.
    Lange M; Hartmann K; Carter MC; Siebenhaar F; Alvarez-Twose I; Torrado I; Brockow K; Renke J; Irga-Jaworska N; Plata-Nazar K; Ługowska-Umer H; Czarny J; Belloni Fortina A; Caroppo F; Nowicki RJ; Nedoszytko B; Niedoszytko M; Valent P
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806685
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Hypereosinophilic syndromes - An enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment.
    Helbig G; Klion AD
    Blood Rev; 2021 Sep; 49():100809. PubMed ID: 33714638
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. CERKL is upregulated in cutaneous squamous cell carcinoma and maintains cellular sphingolipids and resistance to oxidative stress.
    Meyer JM; Lee E; Celli A; Park K; Cho R; Lambert W; Pitchford M; Gordon M; Tsai K; Cleaver J; Arron ST; Mauro TM
    Br J Dermatol; 2021 Jul; 185(1):147-152. PubMed ID: 33393080
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of potential gene drivers of cutaneous squamous cell carcinoma: Analysis of microarray data.
    Zheng Y; Chi S; Li C
    Medicine (Baltimore); 2020 Sep; 99(39):e22257. PubMed ID: 32991423
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Design and characterization of flattening filter for high dose rate
    Ghobadi P; Farhood B; Ghorbani M; Mohseni M
    Comput Biol Med; 2020 Aug; 123():103878. PubMed ID: 32658791
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Risk factors of distant metastasis after surgery among different breast cancer subtypes: a hospital-based study in Indonesia.
    Anwar SL; Avanti WS; Nugroho AC; Choridah L; Dwianingsih EK; Harahap WA; Aryandono T; Wulaningsih W
    World J Surg Oncol; 2020 May; 18(1):117. PubMed ID: 32473643
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.